The emergence of SARS-CoV-2 in Europe and North America.

Worobey M, Pekar J, Larsen BB, Nelson MI, Hill V, Joy JB, Rambaut A, Suchard MA, Wertheim JO, Lemey P. · 2020

Read The emergence of SARS-CoV-2 in Europe and North America. by Worobey M, Pekar J, Larsen BB, Nelson MI, Hill V, Joy JB, Rambaut A, Suchard MA, Wertheim JO, Lemey P. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7810038.txt.

Introduction

Worobey and co-authors reconstruct how SARS-CoV-2 first emerged in Europe and North America. Early spread stories were confused and contested. Some accounts drove national policy choices. Thousands of virus genomes later became available for study.

The team read those genomes to time each introduction. Genetic links show where early cases came from. Separate entries into each continent can be told apart. The work tests claims about very early hidden spread. It also dates when steady transmission took hold. Getting this history right matters for policy. It shows how fast travel can seed a new virus across the world.

Catalog record

CREATORWorobey M, Pekar J, Larsen BB, Nelson MI, Hill V, Joy JB, Rambaut A, Suchard MA, Wertheim JO, Lemey P.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7810038

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The emergence of SARS-CoV-2 in Europe and North America By Michael Worobey, Jonathan Pekar, Brendan B Larsen, Martha I Nelson, Verity Hill, Jeffrey B Joy, Andrew Rambaut, Marc A Suchard, Joel O Wertheim, Philippe Lemey Published in: Science (New York, N.y.) DOI: 10.1126/science.abc8169 ABSTRACT A series of unfortunate events The history of how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread around the planet has been far from clear. Several narratives have been propagated by social media and, in some cases, national policies were forged in response. Now that many thousands of virus sequences are available, two studies analyzed some of the key early events in the spread of SARS-CoV-2. Bedford et al. found that the virus arrived in Washington state in late January or early February. The viral genome from the first case detected had mutations similar to those found in Chinese samples and rapidly spread and dominated subsequent undetected community transmission. The other viruses detected had origins in Europe. Worobey et al. found that early introductions into Germany and the west coast of the United States were extinguished by vigorous public health efforts, but these successes were largely unrecognized. Unfortunately, several major travel events occurred in February, including repatriations from China, with lax public health follow-up. Serial, independent introductions triggered the major outbreaks in the United States and Europe that still hold us in the grip of control measures. Science, this issue p. 571, p. 564 In late 2019, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), ignited a pandemic that has been associated with more than 500,000 deaths globally as of July 2020. As the original outbreak in Hubei province, China, spilled into other countries, containment strategies focused on travel restrictions, isolation, and contact tracing. Given the virus’s exponential growth rate, delaying the onset of community transmission by even a few weeks likely bought government officials valuable time to establish diagnostic testing capacity and implement social distancing plans. Viral genetic sequence data can provide critical information about whether viruses separated by time and space are likely to be epidemiologically linked. Genomic data have suggested differences in the timing, spatial origins, and transmission dynamics of early SARS-CoV-2 outbreaks in multiple North American locations, including Washington state (1, 2); the East Coast of the United States (3, 4); California (5); and British Columbia (BC), Canada (5, 6). The first confirmed U.S. case was associated with a virus strain (“WA1”) isolated in Washington state from a traveler who returned from Wuhan, China, on 15 January 2020 (7). No onward transmission was detected after extensive follow-up in what appeared to be successful containment of the country’s first known incursion of the virus (8). However, subsequent identification of viruses that were genetically similar to WA1—first in Washington, then in Connecticut (3), California (5), BC (6), and elsewhere—raised the possibility that WA1 had actually established chains of cryptic transmission that started on 15 January and went undetected for several weeks (1, 2). If true, this introduction would predate early SARS-CoV-2 community transmission chains documented elsewhere on the continent (3–5) and would establish the Seattle area as the epicenter of the North American epidemic. Hence, it is necessary to resolve this question to determine where the virus first initiated substantial community outbreaks and whether the earliest coast-to-coast spread of the virus within the United States (3) was from west to east or from east to west. In Europe, the first diagnosed case occurred in an employee of an automobile supplier who visited the company’s headquarters in Bavaria, Germany, from Shanghai, China, on 20 January 2020 (9). She had been infected with SARS-CoV-2 in Shanghai (after her parents had visited from Wuhan) (10) and transmitted the virus to a German man who tested positive on 27 January (11) and whose viral genome (“BavPat1”) was sampled on 28 January (10). In total, this outbreak infected 16 employees but was apparently contained through rapid testing and isolation (9). Italy’s first major outbreak in Lombardy, which was apparent by ~20 February 2020, was associated with viruses closely related to BavPat1 but of a separate lineage (designated “B.1”), which differs from BavPat (a lineage “B” virus) by just 1 nucleotide in the nearly 30,000-nucleotide genome. A narrative took hold that the virus from Germany had not been contained but had been transmitting undetected for weeks and had been carried to Italy by an infected German (9, 12). In addition to igniting a severe outbreak in Italy, this B.1 lineage subsequently spread widely across Europe and beyond, initiating outbreaks in many countries, including the intense U.S. outbreak in New York City (NYC) (13, 14). Greater clarity about the effectiveness of Germany’s early contact tracing efforts has implications for the feasibility of controlling the virus through nonpharmaceutical interventions. There are a number of limitations in phylogenetic and spatial inferences drawn from SARS-CoV-2 genomic data. SARS-CoV-2 has a relatively long (~29 kb) positive-sense single-stranded RNA genome that evolves at a rate of <1 × 10−3 substitutions per site per year, amounting to ~2 substitutions per genome per month. This rate is slower than that of most RNA viruses, owing to the “proofreading” activity encoded by the nonstructural gene nsp14 (15). Consequently, the entire global population of SARS-CoV-2 through March 2020 differed by only 0 to 12 nucleotide substitutions from the inferred ancestor of the entire pandemic. Transmission clusters tend to be defined by 1 to 3 nucleotide differences across the entire viral genome. Phylogeographic inferences are further confounded by the relatively low availability of genomic sequence data from locations that experienced early outbreaks, including Italy, Iran, and the original epicenter in Hubei. The combination of the relatively slow rate of SARS-CoV-2 evolution, its rapid dissemination within and between locations, and unrepresentative sampling presents risks for serious misinterpretation. In this study, we investigated fundamental questions about when, where, and how SARS-CoV-2 established itself globally. We developed phylogenetic inferences from multiple sources of information—including airline passenger flow data between potential sources and destinations of viral dispersals early in the pandemic, as well as disease incidence data in Hubei province and other locales that likely affected the probability of infected travelers moving the virus around the globe. By combining a genomic epidemiology approach, which aims to account for the effects of undersampling viral genetic diversity in the epicenter of the pandemic, with consideration of expected evolutionary patterns for a novel pathogen with low diversity, we resolved key questions about how and when the SARS-CoV-2 pandemic unfolded in Europe and North America. EMERGENCE OF SARS-COV-2 IN THE UNITED STATES A key turning point in the U.S. outbreak occurred when researchers sequenced the first viral genome recovered from a putative case of community transmission in the United States (“WA2,” sampled in the Seattle area on 24 February 2020), reporting on 29 February that it was similar to WA1, the viral variant from the first-diagnosed COVID-19 patient (1). This finding led to the suggestion that WA1 might have established cryptic transmission in Washington state in mid-January (1). The researchers did, however, acknowledge the possibility of an independent introduction of WA2 separate from that of WA1. This finding fundamentally altered the picture of the SARS-CoV-2 situation in the United States, playing

Read the complete text